All Stories

  1. Functional Characterization of a Novel Hybrid Peptide with High Potency against Gram-negative Bacteria

    Article • Current Pharmaceutical Design, March 2020, Bentham Science Publishers

    Ammar Almaaytah

  2. Synergism of cationic antimicrobial peptide WLBU2 with antibacterial agents against biofilms of multi-drug resistant Acinetobacter baumannii and Klebsiella pneumoniae

    Article • Infection and Drug Resistance, July 2019, Dove Medical Press

    Ammar Almaaytah, Samer Swedan, Zaina Shubair

  3. The evaluation of the synergistic antimicrobial and antibiofilm activity of AamAP1-Lysine with conventional antibiotics against representative resistant strains of both Gram-positive and Gram-negative bacteria

    Article • Infection and Drug Resistance, May 2019, Dove Medical Press

    Ammar Almaaytah

  4. Design and characterization of a new hybrid peptide from LL-37 and BMAP-27

    Article • Infection and Drug Resistance, April 2019, Dove Medical Press

    Ammar Almaaytah

  5. Recent Advances in Glyoxalase-I Inhibition

    Article • Mini-Reviews in Medicinal Chemistry, January 2019, Bentham Science Publishers

    Ammar Almaaytah

  6. In vivo antimicrobial activity of the hybrid peptide H4: a follow-up study

    Article • Infection and Drug Resistance, September 2018, Dove Medical Press

    Ammar Almaaytah

  7. Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides

    Article • Infection and Drug Resistance, June 2018, Dove Medical Press

    Ammar Almaaytah

  8. Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria

    Article • Drug Design Development and Therapy, November 2017, Dove Medical Press

    Ammar Almaaytah, Gubran Mohammed

  9. Peptide consensus sequence determination for the enhancement of the antimicrobial activity and selectivity of antimicrobial peptides

    Article • Infection and Drug Resistance, December 2016, Dove Medical Press

    Dr. Ya'u Sabo Ajingi, Ammar Almaaytah

  10. Novel glyoxalase-I inhibitors possessing a “zinc-binding feature” as potential anticancer agents

    Article • Drug Design Development and Therapy, August 2016, Dove Medical Press

    Ammar Almaaytah

  11. Dispensing of non-prescribed antibiotics in Jordan

    Article • Patient Preference and Adherence, September 2015, Dove Medical Press

    Ammar Almaaytah

  12. Novel N-substituted aminobenzamide scaffold derivatives targeting the dipeptidyl peptidase-IV enzyme

    Article • Drug Design Development and Therapy, January 2014, Taylor & Francis

    Professor Amjad M. Qandil, Ammar Almaaytah